BNP Paribas Bank New Issues Preliminary Prospectus (Cusip: 05574LHU5)

Did You Invest in BNP Paribas Bank New Issues Preliminary Prospectus (Cusip: 05574LHU5), Linked to the $5,000,000 20-Year Callable Leveraged CMS Spread Linked Notes?

According to BNP Paribas Bank New Issues Preliminary Prospectus (Cusip: 05574LHU5):

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the Notes or determined that this Pricing Supplement is truthful or complete. Any representation to the contrary is a criminal offense. Under no circumstances shall this Pricing Supplement constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these Notes, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification under the securities laws of any such jurisdiction.

Investors ought to be cautious with this type of investment. According to the Financial Industry Regulatory Authority (FINRA):

If you bought the structured product known as BNP Paribas Bank New Issues Preliminary Prospectus (Cusip: 05574LHU5), Linked to the $5,000,000 20-Year Callable Leveraged CMS Spread Linked Notes, and it was sold to you as a safe, liquid, and/or conservative investment, and then you suffered losses, you may have a claim. Contact the attorneys at Sonn Law Group for free consultation.

Image credit: David Avoura King via Flickr